Cargando…
PI3Kinase signaling in glioblastoma
Glioblastoma (GBM) is the most common primary tumor of the CNS in the adult. It is characterized by exponential growth and diffuse invasiveness. Among many different genetic alterations in GBM, e.g., mutations of PTEN, EGFR, p16/p19 and p53 and their impact on aberrant signaling have been thoroughly...
Autores principales: | Lino, M. M., Merlo, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116122/ https://www.ncbi.nlm.nih.gov/pubmed/21063898 http://dx.doi.org/10.1007/s11060-010-0442-z |
Ejemplares similares
-
Advances in immunotherapy for the treatment of glioblastoma
por: Tivnan, Amanda, et al.
Publicado: (2016) -
Focused ultrasound for the treatment of glioblastoma
por: Roberts, Jill W., et al.
Publicado: (2022) -
Notch signaling in glioblastoma: a developmental drug target?
por: Lino, Maria Maddalena, et al.
Publicado: (2010) -
Recent advances in the molecular understanding of glioblastoma
por: Bleeker, Fonnet E., et al.
Publicado: (2012) -
Current trends in mouse models of glioblastoma
por: Miyai, Masafumi, et al.
Publicado: (2017)